Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Oct 13, 2026
- Incorporated
- Delaware
- Filings on record
- 38 filings
- On EDGAR
- CIK 2139097
- Fiscal year ends
- December
- Filer status
- Emerging growth company
News 1
Prospectuses and Registrations 4
Ownership 8 of 27
- SCHEDULE 13G Large holder reported a passive stake Oct 16, 2026
- SCHEDULE 13D Large holder reported an active stake Oct 16, 2026
- SCHEDULE 13D Large holder reported an active stake Oct 16, 2026
- 4 Insider reported a trade Oct 15, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 15, 2026
- 4 Insider reported a trade Oct 13, 2026
- 4 Insider reported a trade Oct 13, 2026
- 3 Insider reported their initial holding Oct 8, 2026
Other 6
- EFFECT Notice that a registration became effective Oct 8, 2026
- CERT Exchange certified a listing Oct 8, 2026
- 8-A12B Registration of a security for exchange listing Oct 6, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Aug 21, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jul 31, 2026
- DRS Draft registration statement, submitted confidentially Jun 26, 2026
Everything here comes from TRex Bio, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.